SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001615219-20-000061
Filing Date
2020-05-15
Accepted
2020-05-15 16:29:34
Documents
54
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A flks-20200331.htm   iXBRL 10-Q/A 835964
2 EX-31.1 slrx20200331ex-311.htm EX-31.1 10704
3 EX-31.2 slrx20200331ex-312.htm EX-31.2 10480
4 EX-32.1 slrx20200331ex-321.htm EX-32.1 8824
  Complete submission text file 0001615219-20-000061.txt   3805131

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flks-20200331.xsd EX-101.SCH 26474
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT flks-20200331_cal.xml EX-101.CAL 49192
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT flks-20200331_def.xml EX-101.DEF 130947
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flks-20200331_lab.xml EX-101.LAB 390086
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flks-20200331_pre.xml EX-101.PRE 246029
18 EXTRACTED XBRL INSTANCE DOCUMENT flks-20200331_htm.xml XML 480750
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36812 | Film No.: 20885831
SIC: 2834 Pharmaceutical Preparations